Ryo Ko
Impact in
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Diagnosis and Treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 43
- Lung Cancer Research Studies 23
- Colorectal Cancer Treatments and Studies 13
- Cancer Immunotherapy and Biomarkers 9
-
- Lung Cancer Treatments and Mutations 34
- Lung Cancer Diagnosis and Treatment 16
- Co-authors
- Kazuhisa Takahashi (30 shared papers)Hirotsugu Kenmotsu (17 shared papers)Akira Ono (20 shared papers)Toshiaki Takahashi (19 shared papers)Takehito Shukuya (20 shared papers)Kazushige Wakuda (16 shared papers)Haruyasu Murakami (19 shared papers)Tateaki Naito (19 shared papers)
- Journals
- BMC Cancer (4 papers)Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Journal of Thoracic Oncology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Ryo Ko
53 papers receiving 544 citations
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 392
- Oncology 299
- Cancer Research 87
- Molecular Biology 122
- Pathology and Forensic Medicine 31
Countries citing papers authored by Ryo Ko
This map shows the geographic impact of Ryo Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Ko more than expected).
Fields of papers citing papers by Ryo Ko
This network shows the impact of papers produced by Ryo Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Ko. The network helps show where Ryo Ko may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryo Ko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 54 | |
| 2 | 2022 | 53 | |
| 3 | 2019 | 46 | |
| 4 | 2015 | 43 | |
| 5 | 2019 | 41 | |
| 6 | 2016 | 37 | |
| 7 | 2018 | 32 | |
| 8 | 2015 | 24 | |
| 9 | 2018 | 20 | |
| 10 | 2023 | 16 | |
| 11 | 2019 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2017 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2014 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2016 | 10 | |
| 18 | 2022 | 10 | |
| 19 | 2021 | 7 | |
| 20 | 2019 | 7 |
About Ryo Ko
Ryo Ko is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Molecular Biology and Epidemiology, having authored 60 papers that have together received 547 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (23 papers), Lung Cancer Diagnosis and Treatment (16 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Immunotherapy and Biomarkers (9 papers), Myasthenia Gravis and Thymoma (7 papers), Neuroblastoma Research and Treatments (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (392 citations), Oncology (299 citations), Cancer Research (87 citations), Molecular Biology (122 citations) and Pathology and Forensic Medicine (31 citations). Ryo Ko has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Kazuhisa Takahashi, Hirotsugu Kenmotsu, Akira Ono, Toshiaki Takahashi, Takehito Shukuya, Kazushige Wakuda, Haruyasu Murakami, Tateaki Naito, Masahiro Endo and Tetsuhiko Taira. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.